Variant report
Variant | nsv879043 |
---|---|
Chromosome Location | chr4:59645426-59799872 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:16)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:16 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IGFBP7-5 | chr4:59727050-59727134 | XLOC_003962 |
2 | lnc-IGFBP7-5 | chr4:59650201-59650426 | XLOC_003962 |
3 | lnc-IGFBP7-5 | chr4:59727050-59727134 | XLOC_003962 |
4 | lnc-IGFBP7-5 | chr4:59713333-59713530 | XLOC_003962 |
5 | lnc-IGFBP7-5 | chr4:59726676-59726773 | XLOC_003962 |
6 | lnc-IGFBP7-5 | chr4:59727050-59727134 | XLOC_003962 |
7 | lnc-IGFBP7-5 | chr4:59727050-59727134 | XLOC_003962 |
8 | lnc-IGFBP7-5 | chr4:59727050-59727134 | XLOC_003962 |
9 | lnc-IGFBP7-5 | chr4:59717359-59717370 | XLOC_003962 |
10 | lnc-IGFBP7-5 | chr4:59727050-59727134 | ENSG00000251339 |
11 | lnc-IGFBP7-5 | chr4:59717135-59717370 | ENSG00000251339 |
12 | lnc-IGFBP7-5 | chr4:59727050-59727134 | XLOC_003962 |
13 | lnc-IGFBP7-5 | chr4:59723790-59723913 | XLOC_003962 |
14 | lnc-IGFBP7-5 | chr4:59648710-59648807 | XLOC_003962 |
15 | lnc-IGFBP7-5 | chr4:59646791-59647291 | XLOC_003962 |
16 | lnc-IGFBP7-5 | chr4:59727050-59727134 | NONHSAT096581 |
No data |
No data |
Variant related genes | Relation type |
---|---|
PDCD6 | miRNA target sites |
KLF4 | miRNA target sites |
FLI1 | miRNA target sites |
PDCD6IP | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1375419 | chr4:59646822-59646823 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs529800861 | chr4:59646874-59646875 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs1375418 | chr4:59646917-59646918 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs563314489 | chr4:59646935-59646936 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs530448641 | chr4:59646999-59647000 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs17237987 | chr4:59647009-59647010 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs534468525 | chr4:59647059-59647060 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs546392072 | chr4:59647092-59647093 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs568186954 | chr4:59647122-59647123 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs535959439 | chr4:59647136-59647137 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs557208557 | chr4:59647137-59647138 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs62302978 | chr4:59647151-59647152 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs114342587 | chr4:59647159-59647160 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs558481916 | chr4:59647170-59647171 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs140141582 | chr4:59647199-59647200 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs71605579 | chr4:59647245-59647246 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs143751126 | chr4:59647246-59647247 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs62302979 | chr4:59647285-59647286 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs115856449 | chr4:59647288-59647289 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs528376108 | chr4:59648717-59648718 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs575272914 | chr4:59648736-59648737 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs545471186 | chr4:59648752-59648753 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs183672941 | chr4:59648772-59648773 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs7665793 | chr4:59648798-59648799 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs571540492 | chr4:59650267-59650268 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs538915378 | chr4:59650282-59650283 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs79710957 | chr4:59650319-59650320 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs572139871 | chr4:59650320-59650321 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs6824066 | chr4:59650357-59650358 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs6846316 | chr4:59650365-59650366 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs576489441 | chr4:59650402-59650403 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs571907500 | chr4:59673409-59673410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552493386 | chr4:59673423-59673424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564804468 | chr4:59673431-59673432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35798062 | chr4:59673433-59673434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs13140955 | chr4:59673434-59673435 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs543352310 | chr4:59673436-59673437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564733532 | chr4:59673483-59673484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs553368897 | chr4:59673525-59673526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1449032 | chr4:59673611-59673612 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs545443937 | chr4:59673634-59673635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1449031 | chr4:59673650-59673651 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs73200759 | chr4:59673665-59673666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184377641 | chr4:59673704-59673705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs17218364 | chr4:59673719-59673720 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs1449030 | chr4:59673724-59673725 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs531222781 | chr4:59673787-59673788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188913065 | chr4:59673798-59673799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571009938 | chr4:59673816-59673817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141909940 | chr4:59673858-59673859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:59673400-59675400 | Enhancers | A549 | lung |
2 | chr4:59673600-59673800 | Enhancers | Placenta | Placenta |
3 | chr4:59673800-59674600 | Weak transcription | Placenta | Placenta |
4 | chr4:59674600-59676000 | Enhancers | Placenta | Placenta |
5 | chr4:59674600-59676200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr4:59674600-59676200 | Enhancers | Placenta Amnion | Placenta Amnion |
7 | chr4:59675200-59676200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr4:59675400-59676200 | Flanking Active TSS | A549 | lung |
9 | chr4:59675600-59676000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr4:59675600-59676200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr4:59675600-59676200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr4:59675600-59676200 | Enhancers | Fetal Intestine Small | intestine |
13 | chr4:59676000-59676800 | Weak transcription | Placenta | Placenta |
14 | chr4:59676200-59677600 | Enhancers | A549 | lung |
15 | chr4:59676200-59677800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr4:59676800-59677400 | Enhancers | Placenta | Placenta |
17 | chr4:59677400-59682800 | Weak transcription | Placenta | Placenta |
18 | chr4:59678000-59678200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr4:59682800-59683200 | Enhancers | Placenta | Placenta |
20 | chr4:59683200-59684600 | Weak transcription | Placenta | Placenta |
21 | chr4:59684600-59685200 | Enhancers | Placenta | Placenta |
22 | chr4:59700600-59701000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
23 | chr4:59707600-59708200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
24 | chr4:59723000-59723200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
25 | chr4:59737800-59738400 | Enhancers | A549 | lung |